This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.06% higher to $660.86 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 2.99% to 4,300.17 and the Dow Jones Industrial Average rising 2.81% to 34,061.06. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $86.56 below its 52-week high ($747.42), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 1.07% to $180.20, Novartis AG ADR (NOVN.EB) rose 0.90% to $88.27, and Amgen Inc. (AMGN) rose 1.68% to $236.10. Trading volume (993,860) eclipsed its 50-day average volume of 638,469.
Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2022.
(END) Dow Jones Newswires
May 04, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.